Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

Using Science to Improve the BLM Wild Horse and Burro Program: A Way Forward reviews the science that underpins the Bureau of Land Management's oversight of free-ranging horses and burros on federal ...

Sarah Bradley is a writer with six years of experience creating personal essays, reported features, and content related to health and parenting topics. Susan Bard, MD, is a board-certified general and ...

Medicare is launching a new pilot program that will require prior approval for 17 health services using artificial intelligence tools. The Wasteful and Inappropriate Service Reduction (WISeR) model is ...

From simple text generation to autonomously powering robotic arms on production lines, AI technology offers enterprises a kaleidoscope of new capabilities. So which aspects of AI advancement have ...

AI-powered bug hunting has changed the calculus of what makes for an effective bounty program by accelerating vulnerability discovery — and subjecting code maintainers to ballooning volumes of AI flaw ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

I never thought that a simple USB hub or USB docking station would excite me so much. I’ve been working with several notebooks and different operating systems for years, constantly switching between ...

A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care. By Reed Abelson and Teddy Rosenbluth Like millions ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...

A pandemic-era program aimed to facilitate hotel and office to affordable housing conversions. After a slow start, and numerous financing and design challenges, its first project is opening in Queens.

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...